Aims: The aim of this survey was to investigate the background of speech-language pathologists and their training needs to provide a profile of the current state of the profession in Mainland China. Methods: A survey was conducted of 293 speech-language therapists. The questionnaire used asked questions related to their career background and had a 24-item ranking scale covering almost all of the common speech-language-hearing disorders. A summary of the raw data was constructed by calculating the average ranking score for each answer choice in order to determine the academic training needs with the highest preference among the respondents. Results: The majority of respondents were female, <35 years old and with a total service time of <5 years. More than three quarters of the training needs with the highest preference among the 24 items involved basic-level knowledge of common speech-language-hearing disorders, such as diagnosis, assessment and conventional treatment, but seldom specific advanced technology or current progress. Conclusion: The results revealed that speech-language therapists in Mainland China tend to be young, with little total working experience and at the first stage of their career. This may be due to the lack of systematic educational programs and national certification systems for speech-language therapists.

1.
Brady MC, Kelly H, Godwin J: Speech and language therapy for aphasia following stroke. Cochrane Database Syst Rev 2012;5: CD000425.
2.
American Speech-Language-Hearing Association: Speech-language pathologists, revised 2015. http://www.asha.org/Students/Speech-Language-Pathologists/.
4.
China Disabled Persons' Federation: Chinese report on disability in 2010. http://www.cdpf.org.cn/sjzx/cjrgk/201206/t20120626_387581.shtml.
5.
Cheng LR: Knowledge transfer between minority and majority world settings and its application to the World Report on Disability. Int J Speech Lang Pathol 2013;15:65-68.
6.
Li SL: Speech therapy development and prospects in Mainland China. The Third Sino-Japan Academic Symposium of Rehabilitation Medicine, Beijing, 2006.
7.
Yuen KC: Training a new generation of speech-language pathologists with competences in the management of literacy disorders and learning disabilities in Hong Kong. Folia Phoniatr Logop 2014;66:197-205.
8.
American Speech-Language-Hearing Association: American Speech-Language-Hearing Association's evidence maps of the National Center for Evidence-Based Practice in Communication Disorders. http://ncepmaps.org/spokenlanguage/.
9.
US Bureau of Labor Statistics: Speech-language pathologists 2012. http://www.bls.gov/ooh/healthcare/speech-language-pathologists.htm#tab-3.
10.
Japanese Association of Speech-Language-Hearing Therapists (JAS): Data based on 2003 survey (in Japanese). https://www.jaslht.or.jp/ e_top.html.
11.
Iitaka K, Otomo K: Some issues of Japanese speech-language-hearing therapy education. Folia Phoniatr Logop 2010;62:228-233.
12.
Fernandes FD, Wertzner HF: Competence-based curricula for the education of speech-language pathologists and audiologists in Brazil. Folia Phoniatr Logop 2014;66:176-182.
13.
The Speech-Language-Hearing Association of Taiwan. http://www.slh.org.tw/index.php?do=page&tpid=1&id=1001.
14.
American Speech-Language-Hearing Association (ASHA): Standards for accreditation for graduate education programs in audiology and speech-language pathology 2014. http://www.asha.org/Academic/accreditation/accredmanual/section3/.
15.
Iitaka K: Issues of Japanese speech therapy education considering the 1995 Guidelines of International Association of Logopedics and Phoniatrics (IALP). Folia Phoniatr Logop 2006;58:41-47.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.